000			01881 a2200517 4500
005			20250518042725.0
264		0	_c20190826
008			201908s 0 0 rus d
022			_a1997-7298
024	7		_a10.17116/jnevro20191192273 _2doi
040			_aNLM _beng _cNLM
100	1		_aBoyko, A N
245	0	0	_a[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a]. _h[electronic resource]
260			_bZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _c2019
300			_a73-85 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial
650	0	4	_aAdjuvants, Immunologic
650	0	4	_aHumans
650	0	4	_aInterferon beta-1a _xtherapeutic use
650	0	4	_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy
650	0	4	_aTreatment Outcome
700	1		_aBosenko, L P
700	1		_aVasilovskiy, V V
700	1		_aVolkova, L I
700	1		_aZakharova, M N
700	1		_aKotov, S V
700	1		_aLekomtseva, E V
700	1		_aNegrich, T I
700	1		_aParshina, E V
700	1		_aPatrusheva, O P
700	1		_aProkopenko, S V
700	1		_aSazonov, D V
700	1		_aTimchenko, L V
700	1		_aTrinitatskiy, Yu V
700	1		_aKhabirov, F A
700	1		_aKhavunka, M Ya
700	1		_aChichanovskaya, L V
700	1		_aSherman, M A
700	1		_aIvanov, R A
700	1		_aLin'kova, Yu N
700	1		_aStukalina, E Yu
700	1		_aZinkina-Orikhan, A V
700	1		_aObukhova, I G
773	0		_tZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _gvol. 119 _gno. 2. Vyp. 2 _gp. 73-85
856	4	0	_uhttps://doi.org/10.17116/jnevro20191192273 _zAvailable from publisher's website
999			_c29756465 _d29756465